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Abstract:  
Annexin A2 (AnxA2) is a multifunctional and -compartmental protein whose subcellular 
localisation and functions are tightly regulated by its post-translational modifications. AnxA2 
and its Tyr23 phosphorylated form (pTyr23AnxA2) are involved in malignant cell 
transformation, metastasis and angiogenesis. Here we show that H2O2 exerts rapid, 
simultaneous and opposite effects on the Tyr23 phosphorylation status of AnxA2 in two 
distinct compartments of rat pheochromocytoma (PC12) cells. Reactive oxygen species 
induce dephosphorylation of pTyr23AnxA2 located in the PML bodies of the nucleus, while 
AnxA2 associated with F-actin at the cell cortex is Tyr23 phosphorylated. The H2O2-induced 
responses in both compartments are transient and the pTyr23AnxA2 accumulating at the cell 
cortex is subsequently incorporated into vesicles and then released to the extracellular space. 
Blocking nuclear export by leptomycin B does not affect the nuclear pool of pTyr23AnxA2, 
but increases the amount of total AnxA2 in this compartment, indicating that the protein may 
have several functions in the nucleus. These results suggest that Tyr23 phosphorylation can 
regulate the function of AnxA2 at distinct subcellular sites.  
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Introduction 
Annexin A2 (AnxA2) is a multifunctional protein and a member of the Annexin superfamily 
of proteins initially characterised by their Ca2+- and lipid-binding properties (Gerke and Moss, 
2002; Moss and Morgan, 2004; Gerke et al., 2005; Singh, 2007; Bharadwaj et al., 2013). 
Additional AnxA2 ligands include the EF-hand protein S100A10, which can form a 
heterotetramer with AnxA2 (Gerke and Moss, 2002; Gerke et al., 2005), F-actin (Gerke and 
Weber, 1984; Filipenko and Waisman, 2001), mRNAs (Vedeler and Hollas, 2000; Filipenko 
et al., 2004; Aukrust et al., 2007; Vedeler et al., 2012) and plasminogen/plasmin (Flood and 
Hajjar, 2011; Hedhli et al., 2012). The monomeric 39 kDa (36 kDa by SDS-PAGE) AnxA2, 
consists of two principal domains; a 33 kDa C-terminal core structure folded into a tightly 
packed α-helical conformation and a unique N-terminal region of 3-4 kDa (Rosengarth and 
Luecke, 2004).  
    Posttranslational modifications (PTMs) are believed to be important for discrimination 
between the different functions of AnxA2. Three major phosphorylation sites are located in 
the N-terminal region: Ser11 (counting the first Ser as Ser1) (Jost and Gerke, 1996), Ser25 
(Gould et al., 1986) and Tyr23 (Glenney and Tack, 1985). AnxA2 is also subjected to other 
PTMs including N-terminal acetylation of Ser1 (Johnsson et al., 1988), S-glutathiolation of 
Cys8 (Sullivan et al., 2000), polyubiquitination (Lauvrak et al., 2005) and sumoylation (Caron 
et al., 2015).  
    AnxA2 was originally identified as a major cellular substrate of viral Src (Erikson and 
Erikson, 1980; Radke et al., 1980) and is also a substrate of other Src family Tyr kinases 
(Matsuda et al., 2006), as well as receptor Tyr kinases (Rothhut, 1997) such as the insulin 
receptor kinase (Rescher et al., 2008) leading to a rapid increase in cortical actin (Vedeler et 
al., 1991). It is involved in the regulation of actin dynamics (de Graauw et al., 2008; Rescher 
et al., 2008; Hayes and Moss, 2009), as phosphorylation of Tyr23 has been shown to reduce 
the ability of the AnxA2 tetramer to bind and bundle F-actin (Hubaishy et al., 1995; Filipenko 
and Waisman, 2001), and also induce cell scattering and branch formation (de Graauw et al., 
2008). Furthermore, Tyr23 phosphorylation is required for stable binding of AnxA2 to 
endosomes, transport from early to late endosomes (Morel and Gruenberg, 2009), association 
of the protein with lipid rafts and multivesicular bodies (MVB), as well as its subsequent 
localisation to the lumen of exosomes (Valapala and Vishwanatha, 2011). AnxA2 is up-
regulated in several cancer types (Lokman et al., 2011) and in some cancer cell lines only 
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phosphorylated AnxA2 is detected (Chiang et al., 1996), supporting a role for AnxA2 
phosphorylation in cell survival and proliferation (Kumble et al., 1992; Chiang et al., 1996).  
    AnxA2 is also a redox-sensitive protein (reviewed by (Madureira and Waisman, 2013). 
Cys8 in AnxA2 can be oxidised in response to TNF-α and exogenous H2O2 (Sullivan et al., 
2000; Caplan et al., 2004) and oxidation/glutathiolation inhibits its interaction with liposomes 
and F-actin (Caplan et al., 2004). Oxidised AnxA2 can subsequently be reduced by the 
thioredoxin system. Therefore, it has been hypothesised that AnxA2 participates in a redox 
cycle and can degrade several molecules of H2O2 (Madureira et al., 2011). Accordingly, 
depletion of AnxA2 led to increased protein oxidation in response to oxidative stress, both at 
cell and tissue levels (Madureira et al., 2011). Up-regulation of AnxA2 in response to H2O2-
induced oxidative stress has been reported for several cell types (Tanaka et al., 2004; Kim et 
al., 2011; Madureira et al., 2011) and its phosphorylation is also increased under these 
conditions (Tanaka et al., 2004; Matsuda et al., 2006). A recent study concluded that H2O2-
induced Tyr23 phosphorylation of AnxA2 occurs via the metalloproteinase/sphingolipid 
pathway (Cinq-Frais et al., 2015). The protein has also been shown to reside in the nucleus, 
where it contributes to the protection of DNA in cells exposed to H2O2 and other genotoxic 
agents (Madureira et al., 2012). Brief temperature stress (heat shock) of endothelial cells can 
also induce Tyr23 phosphorylation of AnxA2 and its subsequent translocation via an 
unconventional secretory pathway to the extracellular surface of the plasma membrane (PM) 
(Deora et al., 2004). Moreover, in cultured cone photoreceptor cells, the excitatory 
neurotransmitter Glu stimulates the translocation of Tyr23 phosphorylated AnxA2 
(pTyr23AnxA2) to the cell surface (Valapala et al., 2014). Excessive stimulation 
(exitotoxicity) of neurons e.g. by Glu can both be induced by, as well as induce oxidative 
stress (Mattson, 2003), and both exitotoxicity and oxidative stress have been implicated in 
neurodegenerative diseases. AnxA2 is expressed in subpopulations of neurons found in 
different brain regions, mainly localised to the intra- or extracellular surface of the PM and 
dendritic lipid rafts (Zhao et al., 2004; Zhao and Lu, 2007). It is also upregulated in response 
to neuronal injury (de la Monte et al., 1995). 
   Generally, AnxA2 is localised to the cytoplasm, associating with both endomembranes and 
filamentous (F)-actin (Hayes et al., 2004; Grieve et al., 2012). However, a smaller pool of 
AnxA2 is also found in the nucleus (Vishwanatha et al., 1992; Eberhard et al., 2001; Liu and 
Vishwanatha, 2007), where it – in addition to DNA protection – participates in DNA 
replication by associating with a primer recognition protein complex (Jindal et al., 1991). 
Further, AnxA2 is involved in transcription by activating the transcription factors STAT3 and 
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STAT6 (Das et al., 2010; Wang, Y.-q. et al., 2012). Nuclear fractions contain phosphorylated 
form(s) of AnxA2, whose appearance in the nucleus depends on the stage of the cell cycle 
(Liu et al., 2003).  
    How AnxA2 is targeted to the nucleus remains poorly understood, as the protein does not 
appear to contain a nuclear localisation signal (NLS). However, due to the presence of a 
nuclear export signal (NES) in its N-terminus, AnxA2 can be rapidly exported from the 
nucleus, showing that it acts as a nuclear shuttle protein (Eberhard et al., 2001). It has been 
hypothesised that the retention of AnxA2 in the nucleus could be due to the masking of the 
NES by ligand interactions and/or phosphorylation (Liu and Vishwanatha, 2007). Although 
phosphorylation affects both the nuclear import and export of AnxA2 (Eberhard et al., 2001; 
Liu et al., 2003; Yan et al., 2007; Luo et al., 2008; Grindheim et al., 2014), the detailed 
mechanisms of these events remain to be elucidated. 
    Here we show that nuclear pTyr23AnxA2 is rapidly dephosphorylated in response to 
oxidative stress, while AnxA2 localised to the cell cortex concomitantly undergoes Tyr23 
phosphorylation. These are two separate events and do not involve the translocation of 
AnxA2 from the nucleus to the peripheral cytoplasm. These results suggest that Tyr23 
phosphorylation can alter the function of AnxA2 at distinct sub-cellular sites.  
Results 
Localisation of pTyr23AnxA2 under normal and oxidative stress conditions 
In accordance with previous reports on the nuclear localisation of AnxA2 (Vishwanatha et al., 
1992; Liu et al., 2003; Liu and Vishwanatha, 2007; Madureira et al., 2012), 
immunofluorescence (IF) microscopy of rat pheochromocytoma (PC12) cells, using a 
monoclonal antibody specifically reacting with the Tyr23 phosphorylated form of AnxA2 
(pTyr23AnxA2) (Raddum et al., 2013; Bouwman et al., 2014), revealed a punctate nuclear 
pattern in many cells, in addition to a weaker diffuse cytoplasmic staining (Fig. 1A-B). 
However, the nuclear signal was highly variable, with only a subset of the cells showing 
intensive punctate staining (Fig. 1A, compare cells at arrows). Since the nuclear expression of 
AnxA2 appears to be regulated by the cell cycle (Liu et al., 2003; Wang and Lin, 2014), we 
next investigated the possible co-appearance of pTyr23AnxA2 and the proliferating cellular 
nuclear antigen (PCNA), a marker for the S phase. Based on its variable nuclear patterns, the 
latter also provides a marker for the different sub-phases of the S phase (Celis and Celis, 
1985). According to our results, pTyr23AnxA2 is absent from the nucleus during most of the 
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S phase (Fig. 1A,B), but becomes detectable in cells at the late S-phase, which typically 
contain PCNA-positive spotty structures close to the inner nuclear membrane (see arrows in 
Fig. 1B2, B3). 
     Since AnxA2 is known to act in mRNA transport (Mickleburgh et al., 2005; Hollas et al., 
2006; Vedeler et al., 2012) and has been suggested to accumulate in the nucleus of cells 
exposed to oxidative stress (Madureira et al., 2012), we next examined the localisation of 
pTyr23AnxA2 in PC12 cells after the addition of exogenous H2O2 to the culture medium. 
Remarkably, already after 15 min incubation in the presence of H2O2, the nuclear pool of 
pTyr23AnxA2 was greatly diminished and the phosphorylated protein was found in the 
cytoplasm, predominantly localised to the cortical region close to the PM (Fig. 1C-F). By 
inducing oxidative stress, the different concentrations of H2O2 (300 µm or 1 mM) affected the 
cortical localisation of pTyr23AnxA2 in a dose-dependent manner (Fig. 1C-F), but not that of 
total AnxA2 (Fig. 1I-II).   
     To verify the specificity of the observed response, PC12 cells were grown for up to 24 h in 
low oxygen (2% O2) atmosphere to induce hypoxia, another form of oxidative stress. Notably, 
this treatment had negligible effect on the subcellular localisation of pTyr23AnxA2 (Fig. 2B). 
Furthermore, when the cells were pre-treated with N-acetyl-cysteine (NAC), an antioxidant 
and free radical scavenging agent (Aruoma et al., 1989), the localisation of pTyr23AnxA2 
was not affected by the subsequently added H2O2 (Fig. 2F).  
     The altered distribution of pTyr23AnxA2 in H2O2-treated cells can be explained in two 
ways. One possibility is that pTyr23AnxA2 is first exported from the nucleus the cytoplasm 
and then transported to the cell cortex. Alternatively, nuclear pTyr23AnxA2 could become 
dephosphorylated, while a separate PM-associated pool of AnxA2 undergoes Tyr23 
phosphorylation. To distinguish between these possibilities, we followed the process in more 
detail in a time course experiment where the cells prior to fixation were treated for 1, 5, 10 or 
15 min with 1 mM H2O2 (Figs. 3B-E). Already 1 min after H2O2 addition, pTyr23AnxA2 was 
detected in the vicinity of the PM (Fig. 3B, arrow). Subsequently, the cortical signal gradually 
increased and after 15 min the bulk of pTyr23AnxA2 was found close to the PM (Fig. 3E), as 
described above (Fig. 1). In addition, to study the reversibility of the process, H2O2 was 
removed after 15 min and the cells were incubated for 1, 5, 10, or 15 min in H2O2-free 
medium (Fig. 3F-I). Notably, following H2O2 wash-out, the cortical signal gradually 
decreased and pTyr23AnxA2 rapidly reappeared in the nucleus, resuming after 15 min a 
localisation pattern similar to that seen in untreated cells. The rapid cortical appearance of 
pTyr23AnxA2 after H2O2 addition (Fig. 3B), and its presence both in the nucleus and the 
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periphery of the same cells (Fig. 3F-G) indicate that the observed shift in pTyr23 AnxA2 
distribution is not due to the relocation of the protein. Accordingly, the disassembly of 
microtubules by nocodazole had no effect on the cellular distribution of pTyr23AnxA2 either 
in control or H2O2-treated cells (Fig. 3K,M), ruling out the involvement of microtubule-
dependent transport in this process. 
pTyr23AnxA2 at the PM initially associates with cortical F-actin in H2O2-treated cells  
Previous studies have shown that Tyr23 phosphorylation of AnxA2 results in the translocation 
of the protein from the cytoplasm to both the intra- and extracellular sides of the PM (Deora et 
al., 2004; Rescher et al., 2008; Grieve et al., 2012). To determine the topology of the PM-
associated pTyr23AnxA2, the culture medium during the 15 min H2O2-treatment was 
supplemented with EGTA, which inhibits the calcium-dependent interaction of AnxA2 with 
the extracellular matrix (ECM) and results in its release from the extracellular side of the PM. 
However, the presence of EGTA in the medium during the incubation and subsequent 
washing of cells had no effect on the PM-association of pTyr23AnxA2 (Fig. 4A). 
     Generally, by inducing the pile-up of cortical F-actin, oxidative stress results in a more 
rounded cell shape. Co-staining of the H2O2-treated cells (15 min) with the pTyr23AnxA2 
antibody and phalloidin showed that the phosphorylated protein closely associates with F-
actin at the cytoplasmic side of the PM (Fig. 4B). Treatment of cells with latrunculin B (Lat-B) 
results in the dissociation of the filament bundles of F-actin and the formation of actin 
aggregates (Wakatsuki et al., 2001) (Fig. 4C). Following this treatment, pTyr23AnxA2 loses 
its close association with actin. However, pTyr23AnxA2 is still associated with the 
structurally altered PM, particularly at the sites of cell-cell contact (Fig. 4C). 
Oxidative stress causes the incorporation of pTyr23AnxA2 into extracellular vesicles   
The above results showed that 15 min after H2O2 addition, pTyr23AnxA2 is found associated 
with cortical F-actin. Since this phosphorylated form of AnxA2 has previously been localised 
to endosomes, MVBs, their lumenal exosomes, as well as to the ECM (Deora et al., 2004; 
Morel and Gruenberg, 2009; Valapala and Vishwanatha, 2011; Zheng et al., 2011), it was of 
interest to follow the fate of the cortical pTyr23AnxA2 in the H2O2-treated cells. For this 
purpose, cells were treated for 15 min, 1 h or 2 h with H2O2 (1 mM), followed by the isolation 
of both the ECM proteins (by EGTA treatment) and the extracellular vesicles (EVs; including 
exosomes derived from MVB) from the culture media. Trypan Blue treatment of PC12 cells 
after H2O2 treatment showed no effect of the treatment on viability up to 1 h and about 60% 
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viability after 2 h (data not shown). Immunoblotting analysis showed the presence of the total 
AnxA2 in the ECM of control cells, and its reduction in response to H2O2, while no 
pTyr23AnxA2 was detected in this fraction (Fig. 5A, lanes 1-4). The high-molecular-mass 
forms of pTyr23AnxA2 could be detected in the ECM fraction only upon strong over-
exposure of the blot (data not shown). By contrast, H2O2-treatment resulted in the association 
of pTyr23AnxA2 with EVs (Fig. 5A, lanes 5-8), with a peak observed at 1 h (Fig. 5A, lane 7). 
CD63, a marker for late endosomes, MVBs and exosomes (Andreu and Yanez-Mo, 2014), 
was also included in the analysis to distinguish between EV and ECM proteins. The absence 
of CD63 from the exosomal fraction prior to H2O2 addition (Fig. 5A, lane 5) indicates the 
purity of the exosome-depleted medium used, as well as its validity as an EV (“exosomal”) 
marker. Tumour susceptibility gene 101 (TSG-101) was also observed in EVs with a peak at 1 
h after H2O2 treatment (Fig. 6A, lane 7). Our preliminary results indicate that PC12 cells 
preincubated with exosomes isolated from the medium of H2O2-treated (1 h) cells become 
“primed” to better tolerate their subsequent exposure to H2O2 (1h), increasing their viability 
from ~84% to about ~93% (data not shown). This observation is in accordance with results 
obtained with MC/9 cells (Eldh et al., 2010). Also, it was evident that the fluorescent signals 
corresponding to pTyr23 phosphorylated AnxA2 and total AnxA2 at the cell cortex increase 
in cells preincubated with exosomes and subsequently exposed to H2O2 (15 min). This finding 
suggests that the preincubation gives rise to an increased expression of AnxA2 (data not 
shown), possibly representing an adaptation to oxidative stress (Madureira et al., 2011).  
    The predominant presence of pTyr23AnxA2 as high-molecular-mass forms indicates that 
the phosphorylated protein has also undergone other covalent PTMs, e.g. ubiquitination or 
sumoylation. Thus, by immunoprecipitation of AnxA2 present in EVs, it was shown that 
pTyr23AnxA2 is indeed ubiquitinated (Fig. 5B). Furthermore, the localisation of 
pTyr23AnxA2 at the PM is transient (Fig. 5C1-C5). 
 
Inhibition of Src kinases inhibits Tyr23 phosphorylation of AnxA2 at the PM 
To further study the Tyr23 phosphorylation of AnxA2, the PC12 cells were treated with PP2, 
a selective inhibitor of Tyr kinases of the Src-family (Hanke et al., 1996) and subjected to IF 
or cell fractionation and Western blot analyses. Pre-treatment with PP2 inhibited the H2O2-
dependent Tyr23 phosphorylation of AnxA2 at the PM (Fig. 6E). By contrast, in cells pre-
treated with PP3, a non-functional analogue of PP2, and subsequently exposed to H2O2, 
pTyr23AnxA2 was still readily detectable at the PM (Fig. 6F). PP2 did not appear to affect 
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the nuclear pTyr23AnxA2 in control cells that were not exposed to H2O2, indicating that this 
pool displays a relatively stable Tyr phosphorylation status (Figs. 6B,G). In the nuclear and 
cytoplasmic fractions of PC12 cells total AnxA2 is mainly present in its 39 kDa form, in 
addition to some high-molecular-mass bands (Fig. 6G). By contrast, pTyr23AnxA2 is 
predominantly present as high-molecular-mass forms, which appear to be enriched in the 
nuclear fraction compared to the cytoplasm (Fig. 6G). Moreover, in response to PP2 treatment 
the amount of the 39 kDa form of pTyr23AnxA2 decreased, while its high-molecular-mass 
forms were largely unaffected (Fig. 6G). The Src kinase in the cytoplasm is activated in 
response to 15 min H2O2 treatment (Fig. 6H). 
 
Nuclear localisation of pTyr23AnxA2 
Since the nuclear pTyr23AnxA2 displays a predominantly punctate pattern, we first addressed 
its possible association with nuclear speckles by co-staining the cells with an antibody against 
the marker protein Fox3. The two proteins showed no co-localisation (Fig. 7A), and 
interestingly, cells with high nuclear expression of pTyr23AnxA2 typically showed low levels 
of Fox3, and vice versa (Fig. 7A). Total AnxA2 partially co-localised with another nuclear 
speckle marker, SC-35 (Fig. 7B, arrows). However, it should be noted that both proteins 
showed relatively wide-spread distributions in the nucleus, and their overall staining patterns 
were quite dissimilar. Cells with high nuclear expression of total AnxA2 frequently also 
contained strong SC-35-positive puncta, whereas part of the cell population displayed low 
expression of both proteins (Fig. 7B). We also compared the localisation of pTyr23AnxA2 
with the nucleolar marker fibrillarin, but detected no co-localisation (data not shown). Since 
an apparent partial co-localisation of AnxA2 and SC-35 was observed, overall transcription 
was inhibited by actinomycin D (AcD), resulting in the formation of RNA-containing bodies 
that typically contain the histone γ-H2AX (Mischo et al., 2005). Whereas very little overlap 
was observed in untreated cells, the AcD-treatment resulted in apparent partial co-localisation 
of γ-H2AX and pTyr23AnxA2 (data not shown). However, the two proteins display distinct 
patterns in many cells and their expression levels are frequently inversely related. AcD may 
also cause DNA damage and γ-H2AX has been used as a marker for this event (Sharma et al., 
2012). Thus, we reduced the AcD concentration to avoid DNA damage and investigated the 
possible association of pTyr23AnxA2 with the promyelocytic leukemia (PML) bodies. 
Notably, co-localisation was observed both in untreated (Fig. 7C) and, in particular, AcD-
treated cells (Fig. 7D). We observed that following AcD treatment both PML and 
pTyr23AnxA2 displayed a relatively diffuse nuclear distribution with small foci, in Jo
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accordance with the previously reported formation of PML microbodies in response to AcD 
(Eskiw et al., 2004). Also, the overall patterns of pTyr23AnxA2 and PML were more similar 
than observed for the other nuclear markers tested. 
    PML bodies are considered as a dynamic multifunctional nuclear compartment. They have 
been implicated in transcription, apoptosis and DNA-damage and/or may represent a storage 
site for inactive proteins within the nucleus (Lallemand-Breitenbach and de The, 2010). To 
further address the proposed role of nuclear pTyr23AnxA2, and AnxA2 in general, in mRNA 
export from the nucleus, we employed leptomycin B (LmB) to inhibit CMR1-mediated 
nuclear export (Liu et al., 2003; Kazami et al., 2014). While the nuclear signal of 
pTyr23AnxA2 remains unaffected by the treatment (Fig. 8A-B), the amount of total AnxA2 
evidently increases in the nucleus (Fig. 8C-D). It should be noted that more cells display 
AnxA2-positive than pTyr23AnxA2-positive nuclei (Fig. 8A-D), possibly indicating more 
than one function of AnxA2 in the nucleus. 
Discussion 
Role of Annexin A2 in oxidative stress response 
H2O2 and other reactive oxygen species (ROS) are highly reactive compounds capable of 
damaging a variety of macromolecules, including proteins, lipids and DNA. They have been 
implicated in various disorders, such as Alzheimer’s and Parkinson’s disease, diabetes and 
cancer. Besides being a by-product of the mitochondrial respiratory chain, low levels of H2O2 
can also be produced by different cells and tissues in response to various ligands, such as 
certain growth factors, insulin, cytokines and angiotensin II. H2O2 participates in receptor 
signalling, cell growth, proliferation, apoptosis and senescence, and is associated with 
increased pTyr-dependent signalling (Rhee, S. G. et al., 2000; Chiarugi and Cirri, 2003; Rhee 
et al., 2003; Lambeth, 2004; Milton and Sweeney, 2012). Furthermore, H2O2 can also induce 
fully reversible protein oxidation. For example, it can induce reversible glutathiolation of Cys 
residues, as exemplified by Cys8 of AnxA2 (Caplan et al., 2004), which is involved in several 
aspects of cellular protection against oxidative stress. Transcription factors, such as nuclear 
factor κ-B, activator-protein I, hypoxia-inducible factor and p53, as well as the p21/Ras 
family of proto-oncogenes contain reactive Cys-residues that can be oxidised by H2O2 
(Chiarugi and Cirri, 2003). AnxA2 has been suggested to function in DNA repair (Madureira 
et al., 2012), as an antioxidant by being a substrate of thioredoxin (Madureira et al., 2011) and 
its depletion increases protein oxidation and ROS levels, as well as cell death in response to 
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oxidative stress or ROS-producing drugs. Long-term treatment of 293T and MCF7 cells with 
100 µM H2O2 results in up-regulation of AnxA2. Up-regulation of AnxA2 via VEGF and 
ERK signaling is also caused by hypoxia in osteoblastic and cervical epithelial cells (Denko et 
al., 2000; Genetos et al., 2010). 
     In this study, the final concentration of H2O2 in the culture medium was 1 mM, i.e. the 
same concentration as has recently been applied to investigate the effect on nuclear AnxA2 
(Madureira et al., 2012). H2O2 readily traverses the PM reaching an estimated intracellular 
concentration that is 7-10 times lower than the extracellular concentration (reviewed by 
(Stone and Yang, 2006). In our case this would predict an intracellular H2O2 concentration of 
~100-140 µM, which causes oxidative stress. Our key observation was that when PC12 cells 
are exposed to H2O2 the nuclear signal of pTyr23AnxA2 rapidly disappears and, 
concomitantly a new pool of pTyr23AnxA2 appears at the cytoplasmic side of the PM (Fig. 1). 
A similar effect was observed in HeLa cells (data not shown). The change in subcellular 
distribution of pTyr23AnxA2 in PC12 cells could also be induced by lower concentrations of 
H2O2 (50 µM H2O2, predicted to result in an intracellular concentration of ~5 µM), but 
required longer incubation times, as the Tyr23 phosphorylation of cortical AnxA2 was 
observed 2h after the addition of H2O2 (data not shown). When exogenously added H2O2 is 
taken up by cells, its intracellular concentration rapidly decreases due to degradation by 
glutathione peroxidases, catalases and thioredoxin (Hashida et al., 2002; Gulden et al., 2010). 
Consequently, the stimulatory effects on Tyr phosphorylation are rapidly returning to basal 
levels (Lee et al., 1998; Rhee, S. G. et al., 2000). Taking into account the effects of H2O2 on 
pTyr levels and its rapid cellular degradation, as well as to avoid transcriptional effects, we 
decided to employ a higher concentration of H2O2 (1 mM) and short incubation times to 
investigate in detail how H2O2 affects the subcellular distribution of pTyr23AnxA2.  
    As previously reported in the case of nuclear accumulation of total AnxA2 (Madureira et al., 
2012), the dose-dependent, rapid and reversible effects of H2O2 on cellular distribution of 
pTyr23AnxA2 could be blocked by the antioxidant and free radical scavenger NAC (Fig. 
2E,F), indicating specificity. In addition, the cellular distribution of pTyr23AnxA2 was not 
affected by a 15 min (data not shown) or even 24 h (Fig. 2A,B) exposure of cells to hypoxia 
(2% O2), indicating that the altered Tyr23 phosphorylation pattern of AnxA2 is caused by 
ROS, rather than being part of a general stress response to hypoxia. Translocation of the 
heterotetrameric AnxA2-S100A10 complex to the PM has been shown to take place after 30 
min of hypoxia, and is caused by changes in intracellular pH (Monastyrskaya et al., 2008). 
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 A
dv
an
ce
 a
rt
ic
le
Rapid oxidative stress-induced Tyr23 phosphorylation of AnxA2 at the PM 
The disappearance of pTyr23AnxA2 in the nucleus concomitantly with the appearance of 
pTyr23AnxA2 at the PM involves two separate pools of AnxA2. Several findings support this 
conclusion. First, the appearance of pTyr23AnxA2 at the PM takes place already after 1 min 
incubation of cells with H2O2 (Fig. 3). Second, nuclear and cortical pTyr23AnxA2 can be 
detected in the same cells during short time incubation with H2O2 (Fig. 3), and simultaneous 
inhibition of nuclear export with LmB does not affect the appearance of cortical 
pTyr23AnxA2 (data not shown). Third, following H2O2 wash-out pTyr23AnxA2 rapidly 
resumes the localisation pattern seen in untreated cells (Fig. 3). Finally, the cortical 
appearance of pTyr23AnxA2 does not require intact microtubules (Fig. 3), but is blocked by 
pre-treatment of the cells with the Src family inhibitor PP2 (Fig. 6) and the distribution of 
non-phosphorylated AnxA2 does not change in H2O2-treated PC12 cells (Fig. 1I-II). H2O2 
treatment activates the Src kinase in the cytoplasm (Fig. 6), suggesting the involvement of this 
kinase in the pTyr23 phosphorylation of cortical AnxA2. 
   Other stimuli can also induce Tyr23 phosphorylation of AnxA2 and its association with the 
cell periphery. Insulin leads to rapid Tyr23 phosphorylation of a cortical pool of AnxA2 
associated with the accumulated actin filaments. This event is mediated by the insulin 
receptor and not affected by PP2 (Rescher et al., 2008). The association of AnxA2 with both 
insulin and insulin-like growth factor-1 receptors in PC12 cells is reduced upon insulin 
stimulation, which also increases the secretion of AnxA2 (Zhao et al., 2003). Stress conditions 
like hypoxia and heat shock can induce Tyr23 phosphorylation of AnxA2 and its cell surface 
expression in human umbilical vein endothelial cells (HUVECs) (Deora et al., 2004; Huang et 
al., 2011). In line with these data, we previously observed that anti-pTyr23AnxA2 was the 
most potent antibody in inhibiting network formation by HUVECs in a co-culture system 
mimicking several features of angiogenesis (Raddum et al., 2013). Since Tyr23 
phosphorylation of AnxA2 and its association with the PM appear to be involved in malignant 
cell transformation, metastasis and angiogenesis (de Graauw et al., 2008; Mohammad et al., 
2008; Zheng et al., 2011), the detailed characterisation of these events is of importance.  
    H2O2 treatment increases the intracellular Ca
2+ concentration (Wang and Joseph, 2000), 
triggering a conformational change in AnxA2 and increasing its membrane binding 
(Rosengarth and Luecke, 2004). Moreover, PM association of AnxA2 increases the 
accessibility of the Tyr23 residue and lowers the Ca2+ concentration required for 
phosphorylation, thereby enhancing its modification by the Src kinase (Bellagamba et al., 
1997). Higher intracellular Ca2+ levels and pTyr23 phosphorylation lead to the association of Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 A
dv
an
ce
 a
rt
ic
le
AnxA2 with lipid rafts, its transport via endosomes, incorporation into the lumenal exosomes 
of MVBs and delivery to the extracellular space (Valapala and Vishwanatha, 2011). 
    To determine whether the pTyr23AnxA2 appearing at the periphery of H2O2-treated cells is 
located at the intra- or extracellular side of the PM, extracellular Ca2+-binding proteins 
(including AnxA2) were released by EGTA after 15 min exposure of PC12 cells to oxidative 
stress. Evidently, pTyr23AnxA2 was not released under these conditions (Fig. 4A). Further, 
cortical pTyr23AnxA2 overlaps with F-actin (Fig. 4B). The disintegration of actin filaments 
with Lat-B apparently leads to an enrichment of pTyr23AnxA2 at sites of cell-cell contact 
(Fig. 4C), where it also overlapped with β-catenin (data not shown). This is in accordance 
with the results showing that AnxA2 is recruited to VE-cadherin- and β-catenin-containing 
cell-cell junctions in confluent HUVECs, and that its interaction with these complexes is 
independent of F-actin (Heyraud et al., 2008). 
     When the incubation time with 1 mM H2O2 was extended to 2 h, the PM-associated pool 
of pTyr23AnxA2 appeared to decrease considerably (Fig. 5C). Therefore, we investigated the 
appearance of the protein in the ECM or EVs at 0, 15 min, 1 h and 2 h after the exposure of 
cells to H2O2 and obtained evidence for its release in exosome-like vesicles (Raposo and 
Stoorvogel, 2013), with maximum release taking place about 1 h after H2O2 addition. The 
similar patterns of CD63 and TSG-101 compared with pTyr23AnxA2 after H2O2 treatment 
suggest that the latter may be associated with exosomes. It has been shown that oxidative 
stress increases the release of exosomes (Hedlund et al., 2011) and subsequently mediate 
protective messages in mouse mast cells (MC/9) (Eldh et al., 2010). 
    Interestingly, the main bands of pTyr23AnxA2 are about 90 and 120 kDa, indicating 
additional covalent PTM(s), most likely ubiquitination and/or sumoylation. Thus, we 
performed IP of AnxA2 present in exosomes and found that pTyr23AnxA2 is indeed 
ubiquitinated (Fig. 5B). We and others have previously shown that AnxA2, like its closest 
relative Annexin A1 (AnxA1), is ubiquitinated (Lauvrak et al., 2005; Hirata et al., 2010; Deng 
et al., 2012). This modification is stable and does not appear to target the protein for 
degradation (Lauvrak et al., 2005). Furthermore, polyubiquitinated proteins are enriched in 
the lumen of exosomes, as compared to total cell lysates (Buschow et al., 2005). Thus, 
specific PTMs of EV proteins could be linked to intercellular transmission of oxidative stress 
conditions, which is known to take place via exosomes (Eldh et al., 2010; de Jong et al., 2012). 
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Localisation of pTyr23AnxA2 in the nucleus 
Cell fractionation showed the nuclear enrichment of pTyr23AnxA2 and IF microscopy further 
revealed its typical punctate pattern in the nucleus of a subset of PC12 cells. In accordance 
with previous studies (Liu et al., 2003), pTyrAnxA2 was predominantly undetectable in the 
nucleus during S phase of the cell cycle (Fig. 1A,B). Furthermore, pTyr23AnxA2 was mainly 
present in the nucleus as high-molecular-mass forms, indicating that it has undergone covalent 
modifications, e.g. ubiquitination and/or sumoylation. Upon treatment with PP2, the minor 39 
kDa form of pTyr23AnxA2 was decreased, while the nuclear high-molecular-mass forms 
were largely unaffected (Fig. 6), indicating their relatively slow phosphorylation-
dephosphorylation turnover. Covalent PTMs could affect the accessibility of pTyr23AnxA2 to 
modifying enzymes, explaining the stable phosphorylation status of its high-molecular mass 
forms. It should be mentioned that besides exosomes the enrichment of polyubiquitinated and 
sumoylated proteins has been reported also for nuclear PML bodies (Lallemand-Breitenbach 
and de The, 2010; Pankiv et al., 2010). 
     The nuclear pTyr23AnxA2 is mainly localised to the interchromatin space, but excluded 
from the nucleolus (Fig. 7). In addition to residing in strongly fluorescent puncta, the protein 
also displays a more diffuse distribution throughout the nucleoplasm. The punctate pattern is 
similar to that displayed by nuclear speckles or interchromatin granules, which contain 
proteins involved in pre-mRNA processing (Spector and Lamond, 2011). However, 
pTyr23AnxA2 does not seem to associate with nuclear speckles, while total AnxA2 showed 
partial co-localisation with their marker protein SC-35. This is consistent with the 
involvement of AnxA2 in both transcription - via its interaction with the transcription factors 
STAT3 and STAT6 (Das et al., 2010; Wang, Y. Q. et al., 2012) - and mRNA transport 
(Mickleburgh et al., 2005; Vedeler et al., 2012). Interestingly, nuclear 
phosphatidylinositol(4,5)-biphosphate, an AnxA2 ligand (Hayes et al., 2009), also co-
localises to SC-35-positive nuclear structures (Osborne et al., 2001).  
    We observed that inhibition of CMR1-mediated export by LmB leads to nuclear 
accumulation of total AnxA2, but does not affect nuclear pTyr23AnxA2 (Fig. 8), indicating 
Tyr23 phosphorylation “tags” AnxA2 for a specific function in the nucleus. Thus, it is 
possible that the nuclear pool of total AnxA2 may have a role in mRNA transport. By contrast, 
pTyr23AnxA2 is not affected by this treatment, indicating that phosphorylation is connected 
with a specific nuclear function of AnxA2.   
    Oxidative stress by H2O2 also results in the upregulation of Annexin A1 (AnxA1) and its 
redistribution to the perinuclear cytoplasm and the nucleus (Rhee, H. J. et al., 2000). However, Jo
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it remains unknown whether these changes affect the phosphorylation status of AnxA1. Still 
another Annexin, AnxA10, has been found in the nucleus and was shown to relocate in 
doxorubicin- or AcD-treated cells to dark nucleolar caps, where it associates with proteins 
normally found in paraspeckles (Quiskamp et al., 2014). 
     Interestingly, we observed that pTyr23AnxA2 is at least partly localised to nuclear PML 
bodies (Fig. 7). Moreover, nuclear pTyr23AnxA2 is mainly absent during the S-phase of cell 
cycle, but becomes detectable during the late S-phase (Fig. 1) when heterochromatin, a minor 
part of the genome that is typically found around the centromere and telomeres and contains 
noncoding, highly repetitive satellite DNA sequences (John, 1988), is replicated (Leach et al., 
2000). AnxA2 interacts with SMARCA3, a protein involved in ATP-dependent chromatin 
remodelling (Oh et al., 2013) that may also be involved in DNA repair (Gong et al., 2013). 
The presence of pTyr23AnxA2 in nuclear PML bodies, which have been proposed to function 
in heterochromatin remodelling during G2 (Luciani et al., 2006), suggest its involvement in 
this process. Interestingly, PML bodies are dynamic and recruit multiple proteins that have 
been described as oxidative stress-responsible sumoylation factories (Sahin et al., 2014). They 
are believed to be key players in the organisation of compartments/domains within the 
nucleus (Bernardi and Pandolfi, 2007). All the functions of PML bodies may not have been 
unraveled yet, but they appear to participate in such processes as DNA repair, 
apoptosis/senescence and transcription (Lallemand-Breitenbach and de The, 2010). SC-35-
containing nuclear domains have been implicated in the coupled steps of mRNA metabolism 
and transport (Shopland et al., 2002). Thus, it may appear that nuclear AnxA2 has a functional 
role in many diverse processes including RNA transport and DNA repair as previously 
suggested (Mickleburgh et al., 2005; Madureira et al., 2012; Vedeler et al., 2012). 
   In conclusion, H2O2 exerts two simultaneous, but spatially distinct effects on Tyr23-based 
modification of AnxA2: i) dephosphorylation of pTyr23AnxA2 in the nucleus and ii) Tyr23 
phosphorylation of another pool of AnxA2 located close to the PM. Both are specific ROS-
mediated responses caused by the exposure of cells to oxidative stress (Fig. 8E). 
Materials and methods  
Cell cultures and drug treatments 
The rat pheochromocytoma, PC12, cells representing a readily adherent sub-clone derived 
from the original PC12 cell line (Greene and Tischler, 1976) were kindly provided by Prof. 
Eyvind Rødahl, Haukeland Hospital, Bergen, Norway. Cells were recently authenticated and 
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routinely tested for contamination. As described previously (Grindheim et al., 2014), the cells 
were routinely cultured at 37 °C in a humidified atmosphere of 21% O2 supplemented with 5% 
CO2, except for the hypoxic experiments where the O2 level was 2%. As indicated, cells were 
treated with 300 μM or 1 mM H2O2 (Sigma) for 15 min (if not indicated otherwise), 40 mM 
N-acetyl-cysteine (NAC) (Sigma) for 2 h (the pH of the medium was adjusted before addition 
to the cells), 10 μg/ml nocodazole (Sigma) for 30 min, 2 mM ethylene glycol tetraacetic acid 
(EGTA) (Sigma) for 15 min, 20 or 50 µM 4-amino-5-(4-chlorophenyl)-7-
(dimethylethyl)pyrazolo[3,4-d] (PP2) and 4-Amino-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine 
(PP3) (Calbiochem) for 30 min or 5 h, 10 μM latrunculin B (Lat-B) (Sigma) for 4 h, 3 or 9 
μg/ml actinomycin D (AcD) for 1 h or 5 h, respectively, and 20 nM Leptomycin B (LmB) for 
2 h. 
Immunofluorescence 
PC12 cells were grown on poly-L-Lys-coated glass coverslips and treated as indicated. Cells 
were fixed, permeabilised and blocked as described previously (Grindheim et al., 2014), prior 
to staining with primary antibodies against pTyr23AnxA2 (sc-135753, Santa Cruz 
Biotechnologies, 1:20 dilution), AnxA2 (ab41803; Abcam, 1:250 dilution), Fox3 (ABN51, 
Millipore, 1:100 dilution), SC-35 (NB100-1774, Novus Biologicals, 1:500 dilution), PCNA 
(Ab18197, Abcam, 1:200 dilution), PML (Sc-5621, Santa Cruz Biotechnologies, dilution 
1:100), Fibrillarin (C13C3, Cell Signaling, dilution 1:100) and γ-H2A.X (07-164, Millipore, 
dilution 1:200) as indicated. The bound primary antibodies were detected using appropriate 
DyLight 488- or DyLight 594-conjucated Fab2-fragments (Jackson ImmunoResearch 
Laboratories, 1:50 dilution). F-actin was detected directly by Alexa Fluor 594-conjugated 
Phalloidin (Life Technologies). The coverslips were inverted and mounted on objective 
glasses on a small drop of Vectashield mounting medium containing 4’,6-diamino-2’-
phenylindole (DAPI) (Vector Laboratories). Confocal imaging was performed using a Leica 
SP5 AOBS confocal laser scanning microscope equipped with 405 Diode, Argon and Helium 
Neon lasers (Leica Microsystems, Germany). Optical sections were obtained using the 
63x/1.4 NA HCX Plan-Apochromat oil-immersion objective (Leica), ~1 Airy unit pinhole 
aperture and appropriate filter combinations. Confocal images were obtained in Leica 
Application Suite (LAS) AF. Figures were made in Adobe Illustrator CS5.1 except Fig. 8E, 
which was made in ChemBioDraw Ultra 14.0. 
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Cell fractionation  
Nuclear and cytoplasmic fractions were prepared from PC12 cells using the NE-PER reagent 
kit (Thermo Scientific). GAPDH and topoisomerase were highly enriched in the cytoplasmic 
and nuclear fractions, respectively (data not shown), indicating the relative purity of the 
fractions obtained with this method. For the isolation of EVs, PC12 cells were grown in 
medium supplemented with exosome-depleted serum (System Biosciences) and EVs were 
purified from the medium with the ExoQuick kit (System Biosciences) following the 
manufacturer’s instructions as described (Zhu et al., 2014). 
Immunoprecipitation with AnxA2 antibodies   
Proteins (600 µg) present in EVs purified from the medium after their treatment for 1 h with 
H2O2 were immunoprecipitated using monoclonal AnxA2 antibodies (2.75 µg; BD 
Biosciences) coupled to protein G-Sepharose following pre-clearance of the vesicles by 
protein-G Sepharose-coupled normal mouse IgG. Immunoprecipitation was performed in 
NET-buffer (50 mM Tris-HCl of pH 7.4, 150 mM KCl, 0.05% Triton-X100 and 0.2 mM 
CaCl2) ON at 4
oC, whereafter the beads were sedimented for 5 min by centrifugation at 800 x 
g at 4oC. After extensive washing with NET-buffer, the immune complexes were eluted in 
SDS-PAGE sample buffer.  
 
SDS-PAGE and Western blot analysis 
SDS-PAGE was performed using 10% (w/v) gels and the proteins were transferred onto 
nitrocellulose membranes (0.2 µm pore size) by overnight blotting performed at 150 Vh. 
Total AnxA2 or its Tyr23 phosphorylated form were detected using monoclonal antibodies 
directed against AnxA2 (610069; BD Biosciences; 1:1000) or pTyr23AnxA2 (sc-135753, 
Santa Cruz Biotechnologies, 1:200 dilution);(Spijkers-Hagelstein et al., 2013)); CD63 and T-
cadherin were detected using rabbit polyclonal antibodies (EXOAB-CD63A-1; System 
Biosciences; 1:500 and sc-7940; Santa Cruz; 1:1000, respectively); ubiquitin was detected 
using mouse monoclonal antibodies (13-1600 (Ubi-1); Invitrogen; 1:1000). Furthermore, 
activated Src (pTyr416 Src), Src and fibrillarin were detected by monoclonal rabbit antibodies 
from Cell Signaling at a 1:1000 dilution (D49G4, 32G6 and C13C3, respectively). 
Subsequently, HRP-labelled secondary anti-mouse or anti-rabbit antibodies (Bio-Rad/Jackson 
laboratories) were used. The reactive protein bands were visualised using the Supersignal 
West Pico- or Femto Chemiluminescent Substrate kits (Pierce).  Jo
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Figures 
 
 
 
Figure 1 
Due to H2O2-induced oxidative stress the cell cycle stage-dependent nuclear pool of 
pTyr23AnxA2 is diminished and replaced by a cortical pool. PC12 cells were double-
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stained for IF using mono- and polyclonal antibodies against pTyr23AnxA2 (A1 and B1, 
green) and the S-phase marker PCNA (A2 and B2, red), respectively. The insets of the 
merged confocal images (A3 and B3) also show DAPI staining (blue) to highlight the nuclei. 
Cells in late S-phase are indicated by arrows. PC12 cells, either untreated (A1 and B1), or 
treated for 15 min with 300 µM (C, D, I) or 1 mM (E, F, II) H2O2, were subjected to IF 
staining using  specific monoclonal antibodies against pTyr23AnxA2 (C-F, green) or total 
AnxA2 (I, II, green). The images in the insets show also DNA staining by DAPI (blue). Two 
nuclei with different signal intensities for pTyr23AnxA2 are indicated by the arrows in Panel 
A1. The arrows in B2 and B3 indicate cells in late S-phase. Scale bars: 10 µm. This key 
experiment was repeated more than fifteen times and other experiments at least five times. 
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Figure 2 
The distribution of pTyr23AnxA2 is not affected when cells are exposed to either 
hypoxia or to H2O2 after their pre-treatment with an antioxidant. (A and B): PC12 cells 
were grown for 24 h under control (A; normoxia; 21% O2) or hypoxic conditions (B; 2% O2). 
(C-F): The cells were untreated (C), treated for 15 min with 1 mM H2O2 (D), or incubated for 
2 h in the sole presence of 40 mM NAC (E), or the additional presence of 1 mM H2O2 during 
the last 15 min (F). IF staining was carried out using the monoclonal antibody against 
pTyr23AnxA2 (green). The confocal images (insets) also show DNA staining (DAPI; blue) to 
highlight the nuclei. Scale bars: 10 µm. 
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Figure 3 
The effect of H2O2 on the distribution of pTyr23AnxA2 is rapid and reversible and the 
appearance of the H2O2-induced cortical pool of pTyr23AnxA2 does not require intact 
microtubules. PC12 cells were untreated (A, J), or treated with 1 mM H2O2 for 1 (B), 5, (C), 
10 (D) or 15 (E, L) min. Subsequently, the medium containing H2O2 was removed and the 
cells were incubated in fresh medium for 1 (F), 5, (G), 10 (H) or 15 (I) min. Cells were 
incubated for 30 min with 10 µg/ml nocodazole (K, M) to depolymerise microtubules; 1 mM 
H2O2 was present during the last 15 min of nocodazole treatment (M). IF staining was carried 
out using the monoclonal pTyr23AnxA2 antibody (green). The merged confocal images 
(insets) also show DAPI staining (blue) of the nuclei. Scale bars: 10 µm.  
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Figure 4 
The H2O2-induced cortical pool of pTyr23AnxA2 associates with F-actin. (A1-A2): PC12 
cells were treated for 15 min with H2O2 (1 mM) alone (A1), or in the presence of 2 mM 
EGTA and subsequently washed with H2O2- and EGTA-containing medium prior to fixation 
(A2). (B1-C2): Cells were treated with H2O2 (1 mM) alone (B1 and B2), or also incubated in 
the presence of Lat-B to diassemble actin filaments (C1 and C2). C1 corresponds to a single 
optical section, while C2 shows a maximum projection of the same cells to high-light the 
simultaneous collapse of cortical pTyr23AnxA2 and actin in response to Lat-B. 
pTyr23AnxA2 (green) and F-actin (red) were detected using a monoclonal antibody or 
phalloidin, respectively. The merged images (insets in A1, A2 and B2; C1 and C2) also show 
the DAPI-stained nuclei (blue). Scale bars: 10 µm. Panel B3 shows the overlap of the 
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fluorescence intensity profiles of pTyr23AnxA2 (green) and phalloidin (red) across the 
control cell, following the lines indicated in B1 and B2. 
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Figure 5 
Incorporation of ubiquitinated pTyr23AnxA2 into EVs (exosomes) and decrease in the 
cortical pool of pTyr23AnxA2 after prolonged treatment of cells with H2O2. (A): PC12 
cells were grown in exosome-depleted medium in the presence of H2O2 for 0 min (lanes 1 and 
5), 15 min (lanes 2 and 6), 1 h (lanes 3 and 7), or 2 h (lanes 4 and 8). ECM-bound proteins 
were released by EGTA (lanes 1-4), while EVs were isolated from the culture medium by the Jo
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ExoQuick-TC method (lanes 5-8). 100 µg of protein from the EGTA-released fractions (lanes 
1-4) and the control EV fraction (lane 5), or an equal volume of EVs from H2O2-treated cells 
(lanes 6-8) were separated by 10% SDS-PAGE, transferred to nitro-cellulose membranes and 
probed with antibodies against pTyr23AnxA2, total AnxA2, CD63, TSG-101 and T-cadherin, 
as indicated. (B): Following 1 h treatment of PC12 cells with 1 mM H2O2, proteins (600 µg) 
present in purified EVs were immunoprecipitated (IP) by monoclonal AnxA2 antibodies (lane 
1) after pre-clearance of the samples with normal mouse IgG (lane 2). The proteins were 
subjected to 10% SDS-PAGE and immunoblot analysis using monoclonal antibodies against 
pTyr23AnxA2 or ubiquitin by loading half of the IP sample on each gel. The bands 
representing ubiquitinated AnxA2 (brackets) and IgG light chain (LC) are indicated to the 
right. (A and B): Following incubation with HRP-conjugated secondary antibodies and the 
ECL-reagent, the reactive protein bands were detected using the ChemiDocTM XRS+ 
molecular imager. Note that the secondary antibody used in (B) only recognises the IgG light 
chains. Molecular mass standards are indicated to the left. (C): PC12 cells were untreated 
(C1), or treated for 15 (C2), 30, (C3), 60 (C4) or 120 min (C5) with 1 mM H2O2. The 
localisation of pTyr23AnxA2, detected using the monoclonal antibody (green), is shown in 
the merged images, which also display nuclear staining (DAPI; blue). Scale bars: 10 µm. 
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Figure 6 
A-F: Cortical Tyr23 phosphorylation of AnxA2 is blocked by the Src kinase inhibitor 
PP2. PC12 cells were incubated for 5 h either in control medium (A), or medium containing 
20 µM PP2 (B and E) or PP3 (C and F), whereafter H2O2 (1 mM) was added to the control 
(D), PP2- (E) and PP3-pre-treated (F) cells for 15 min. The panels show staining of the cells 
with the antibody against pTyr23AnxA2 (green), while the insets represent merged images 
showing also nuclear staining by DAPI (blue). Scale bars: 10 µm. G: pTyr23AnxA2 is 
mainly present as high-molecular-mass forms in the nucleus. Nuclear and cytoplasmic 
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fractions were prepared from control and PP2-treated cells, as indicated. 150 µg of the 
proteins in each fraction were separated by 10% SDS-PAGE, transferred to nitrocellulose 
membranes for Western blot analysis with monoclonal antibodies against pTyr23AnxA2 or 
AnxA2 with loading controls for the nucleus (fibrillarin) or cytoplasm (tubulin), as indicated. 
H: Src kinase in the cytoplasm is activated during the 15 min treatment  with 1 mM 
H2O2. Nuclear and cytoplasmic fractions were prepared from control and H2O2-treated cells, 
as indicated. 100 µg of the proteins in each fraction were separated by 10% SDS-PAGE, 
transferred to nitrocellulose membranes for Western blot analysis employing antibodies 
against activated (pTyr416 Src is a marker of Src activation) and total Src. The loading 
controls for the nucleus (fibrillarin) and cytoplasm (tubulin) are also indicated. I: 
Distribution of marker proteins in sub-cellular fractions. 100 μg of proteins from the 
cytoplasmic or nuclear fractions derived from PC12 cells were separated by 10% (w/v) SDS-
PAGE and transferred to a nitrocellulose membrane, which was cut in two parts prior to 
Western blot analysis employing antibodies against GAPDH (lower part) or Topoisomerase 
(upper part). Detection of the resulting protein bands was performed using the ChemiDocTM 
XRS+ molecular imager after incubation with HRP-complex conjugated secondary antibodies 
and ECL-reagent. The arrows to the left indicate the protein molecular mass standards. 
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Figure 7  
Nuclear pTyr23AnxA2 is found in PML bodies, but absent in nuclear speckles, while 
AnxA2 is found in SC-35 positive nuclear speckles. PC12 cells were untreated (A1-A3, B1-
B3, C1-C3), or treated for 1 h with 3 μg/ml AcD (D1-D3). The cells were double-stained with 
monoclonal pTyr23AnxA2 (green) (A1,C1,D1) and polyclonal Fox3 (A2) or PML (C2,D2) 
(red) antibodies as indicated. Other cells were double-stained with polyclonal AnxA2 (green) 
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(B1) and monoclonal SC-35 (B2) (red) antibodies. The merged confocal images (A3, B3, C3, 
D3) (insets) also show DAPI staining (blue) of the nuclei. Scale bar: 10 µm. Panels A4, B4, 
C4, D4 show the fluorescence intensity profiles for the two markers indicated, corresponding 
to the cross-sections (from left to right) of control (A, B, C) and AcD-treated (D) cells 
indicated by lines on the images. 
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Figure 8 
Nuclear export of AnxA2, but not of pTyr23AnxA2, is blocked by LmB. PC12 cells were 
untreated (A and C) or treated for 2 h with LmB (B and D), whereafter they were subjected to 
IF staining using monoclonal pTyr23AnxA2 (A and B) or polyclonal AnxA2 antibodies (C 
and D). The higher magnification images in the middle panels also indicate cross-sections of 
nuclei, with the left-to-right orientation of the lines corresponding to the fluorescence 
intensity profiles shown to the right. The insets include DAPI staining (blue) to verify the 
position of the nuclei. Scale bars: 10 µm. (E) A schematic model of the transient Tyr23 
AnxA2 phosphorylation events occurring at two distinct sites in response to H2O2. Upon 
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exposure to H2O2, nuclear Tyr23 phosphorylated AnxA2 in PML bodies rapidly 
dephosphorylates and may become associated with SC-35 positive nuclear speckles. AcD 
increases the localisation of pTyr23AnxA2 in PML bodies suggesting a role in transcription. 
Note that the Tyr23 phosphorylated AnxA2 form is not exported from the nucleus (via the 
CRM1-dependent pathway). At the same time cortical AnxA2 is Tyr23 phosphorylated, 
associates with actin and subsequently with endosomes and multivesicular bodies (MVB) and 
is exported out of the cell in the lumen of exosomes. 
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